Teachers Retirement System of The State of Kentucky Sells 21,617 Shares of Cabot Corporation $CBT

Teachers Retirement System of The State of Kentucky lowered its holdings in shares of Cabot Corporation (NYSE:CBTFree Report) by 54.7% in the fourth quarter, HoldingsChannel reports. The firm owned 17,880 shares of the specialty chemicals company’s stock after selling 21,617 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Cabot were worth $1,185,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of CBT. NewEdge Advisors LLC grew its holdings in Cabot by 2,559.5% during the first quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock worth $82,000 after purchasing an additional 947 shares during the period. Goldman Sachs Group Inc. grew its holdings in Cabot by 32.5% during the first quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock worth $36,802,000 after purchasing an additional 108,645 shares during the period. Empowered Funds LLC grew its holdings in Cabot by 102.6% during the first quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock worth $2,341,000 after purchasing an additional 14,260 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Cabot by 3.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock worth $10,145,000 after purchasing an additional 4,048 shares during the period. Finally, Geneos Wealth Management Inc. grew its holdings in Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares during the period. Institutional investors own 93.18% of the company’s stock.

Cabot Trading Down 1.4%

Shares of CBT stock opened at $75.81 on Thursday. The company has a current ratio of 1.67, a quick ratio of 1.09 and a debt-to-equity ratio of 0.49. The stock has a market cap of $3.96 billion, a P/E ratio of 13.28, a price-to-earnings-growth ratio of 10.19 and a beta of 0.84. The stock has a 50 day simple moving average of $73.56 and a 200 day simple moving average of $70.12. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $83.71.

Cabot (NYSE:CBTGet Free Report) last issued its quarterly earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.13. The business had revenue of $849.00 million during the quarter, compared to analysts’ expectations of $889.11 million. Cabot had a return on equity of 22.82% and a net margin of 8.62%.The firm’s revenue for the quarter was down 11.1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.76 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. On average, research analysts predict that Cabot Corporation will post 6.27 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on CBT shares. Mizuho set a $75.00 price target on Cabot and gave the stock a “neutral” rating in a report on Wednesday, February 4th. Zacks Research upgraded Cabot from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 27th. UBS Group lifted their price target on Cabot from $74.00 to $81.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. Finally, Jefferies Financial Group reiterated a “buy” rating and set a $85.00 price target on shares of Cabot in a report on Wednesday, February 4th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Cabot presently has a consensus rating of “Hold” and a consensus target price of $73.75.

View Our Latest Stock Report on CBT

Cabot Profile

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Further Reading

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.